Big Pharma is offering to reserve vaccines, medicines and tests for low-income nations in preparation for the next pandemic in exchange for a fee and a commitment that governments not impose restrictions on trade.
Ahead of talks on pandemic preparedness at the World Health Organization next week, the industry is lobbying to win a slice of a multibillion-dollar pandemic preparedness fund proposed by the G20 to cover the cost of reserving manufacturing capacity at existing plants.
The International Federation of Pharmaceutical Manufacturers and Associations argues the mechanism would enable the rapid distribution of supplies to low- and middle-income nations in the event of a new Covid-19 variant or the next pandemic.
您已阅读16%（725字），剩余84%（3884字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。